Beta-bloqueante

Applications Angiotensin converting enzyme (ACE) inhibitor. Antihypertensive. References Demolis, P., et al.: Fundam. Clin. Pharmacol., 8, 80 (1994), Vandenburg, M.J., et al.: Br. J. Clin. Pharmacol., 37, 265 (1994),

Stability Hygroscopic Applications Cerivastatin lactone is a metabolite of a competitive inhibitor of HMG-CoA reductase, Cerivastatin (C277000). Cerivastatin lactone shows inhibitory effects on CYP3A4/5 activity. References Ness, C.G., et al.: Arch. Biochem. Biophys., 325, 242 (1996); Steinke, W., et al.: Japan. Pharmacol. Ther., 24, Suppl. 9, S1217 (1996); Sakaeda, T., et. al.: Pharmaceut. Res., 23, 506 (2006)

Applications (S)-4-Hydroxy Propranolol is the main metabolite of (S)-Propranolol (P831795). References Shwed, J., et al.: Xenobiotica, 22, 973 (1992), Fujita, K., et al.: Biol. Pharm. Bull., 22, 446 (1999), Walle, U., et al.: Drug Metab. Dispos., 30, 564 (2002),

Applications A bufadienolide derivative, cardiac steroid, a component of bufadienolides present in the traditional Chinese medicine Chan'su, used therapeutically for the treatment of heart disease, also has been reported as a protective factor in many tumors. Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package References Wang, B., et al.: Biol. Pharm. Bull., 34, 967 (2011), Song, C., et al.: Xiandai Zhongliu Yixue, 18, 1863, 2010.

Applications A dual-selective phosphodiesterase 3/4 inhibitor used in chronic experimental pulmonary hypertension. References Huxtable, R., et al.: Pharmacol. Ther., 47, 371 (1990), Tanaka, K., et al.: Cancer Res., 55, 2927 (1995), Wagner, R., et al.: J. Pharmacol. Exp. Ther., 282, 1650 (1997), Cowan, K., et al.: Nat. Med., 6, 698 (2000), Shankavaram, U., et al.: J. Biol. Chem., 276, 19027 (2001),

Applications Asperosaponin VI is a steroidal extract with anti-inflammatory and antinociceptive activity. long term use has been seen to attenuate cardiac dysfunction. References Choi, J. et al.: J. Med. Food, 8, 78 (2005); Li, C. et al.: Food. Chem. Toxicol., 8, 1432 (2012);

Amino-alcohols, other than those containing more than one kind of oxygen function, their ethers and esters, salts therof, nesoi

Applications (±)-Carvedilol-d4 (ethyl-d4) (CAS# 1133705-56-2) is a useful isotopically labeled research compound.

Applications A Nicorandil (N398500) derivative

Applications Atorvastatin-d5 tert-Butyl Ester is the labeled analogue of Atorvastatin tert-Butyl Ester (A791740), an impurity arising in the synthesis of Atorvastatin (A791750), a selective, competitive HMG-CoA reductase inhibitor. Atorvastatin is the only drug in its class specfically indicated for lowering both elevated LDL-cholesterol and triglycerides in patients with hypercholesterolemia. References Kearney, A.S., et al.: Pharm. Res., 10, 1461 (1993); Heinonen, T.M., et al.: Clin. Ther., 18, 853 (1996); Whitfield, L.R., et al.: Eur. J. Drug Metab. Pharmacokinet., 25, 97 (2000)

Applications A labelled metabolite of Carvedilol (C184625). It is used in the treatment of hypertension. References Sponer, G., et al.: J. Cardiovasc. Pharmacol., 9, 317 (1987), Fujimaki, M., ET AL.: Xenobiotica, 20, 1025 (1990), Ruffolo, R., et al.: Eur. J. Clin. Pharmacol., 38, S82 (1990), Schaefer, W.H., et al.: Drug Metab. Dispos., 26, 10, 958 (1998),

Applications A labelled metabolite of Coumarin. The aglucon of skimmin. Present in many plants. References Schilling, et al.: Nature, 221, 664 (1969), Indahl, S., et al.: Xenobiotica, 1, 13 (1971), Thompson, S.G., et al.: Antimicrob. Agents Chemother., 18, 264 (1980),

Applications 2-Oxo-Zoniporide is an metabolite of Zoniporide, a potent and selective inhibitor of human sodium-hydrogen exchanger isoform1(NHE-1) and protects against cardiac ischemia-reperfusion injury. References Ross, T.W., et al.: Cardiovascular. Drug. Reviews., 21, 17 (2003); Deepak, D., et al.: Drug. Metabol. Dispos., 38, 641 (2010);

Applications Labelled Tranexamic Acid (T714505). Antifibrinolytic agent; blocks lysine binding sites of plasminogen. Hemostatic. References Andersson, et al.: Scand. J. Haematol. 2, 230 (1965), Melander, B., et al.: Acta Pharmacol. Toxicol., 22, 340 (1965), Bonnar, J., et al.: Br. Med. J., 313, 579 (1996), Dunn, C.J., et al.: Drugs, 57, 1005 (1999),